Efficient Synthesis of Benzothiazinone Analogues with Activity against Intracellular Mycobacterium tuberculosis.
- Published in:
- ChemMedChem, 2022, v. 17, n. 6, p. 1, doi. 10.1002/cmdc.202100733
- By:
- Publication type:
- Article
Works matching IS 18607179 AND DT 2022 AND VI 17 AND IP 6
Results: 13
1
2
Cover Feature: Amphiphilic Fullerene‐BODIPY Photosensitizers for Targeted Photodynamic Therapy (ChemMedChem 6/2022).
- Published in:
- ChemMedChem, 2022, v. 17, n. 6, p. 1, doi. 10.1002/cmdc.202200117
- By:
- Publication type:
- Article
3
Front Cover: Efficient Synthesis of Benzothiazinone Analogues with Activity against Intracellular Mycobacterium tuberculosis (ChemMedChem 6/2022).
- Published in:
- ChemMedChem, 2022, v. 17, n. 6, p. 1, doi. 10.1002/cmdc.202200116
- By:
- Publication type:
- Article
4
New Insight into Dearomatization and Decarbonylation of Antitubercular 4H‐Benzo[e][1,3]thiazinones: Stable 5H‐ and 7H‐Benzo[e][1,3]thiazines.
- Published in:
- ChemMedChem, 2022, v. 17, n. 6, p. 1, doi. 10.1002/cmdc.202200021
- By:
- Publication type:
- Article
5
Covalent Fragment Screening Identifies Rgl2 RalGEF Cysteine for Targeted Covalent Inhibition of Ral GTPase Activation.
- Published in:
- ChemMedChem, 2022, v. 17, n. 6, p. 1, doi. 10.1002/cmdc.202100750
- By:
- Publication type:
- Article
6
Recent Advances in Dual BRD4‐Kinase Inhibitors Based on Polypharmacology.
- Published in:
- ChemMedChem, 2022, v. 17, n. 6, p. 1, doi. 10.1002/cmdc.202100731
- By:
- Publication type:
- Article
7
Amphiphilic Fullerene‐BODIPY Photosensitizers for Targeted Photodynamic Therapy.
- Published in:
- ChemMedChem, 2022, v. 17, n. 6, p. 1, doi. 10.1002/cmdc.202100693
- By:
- Publication type:
- Article
8
Intracellular Delivery of Antibodies for Selective Cell Signaling Interference.
- Published in:
- ChemMedChem, 2022, v. 17, n. 6, p. 1, doi. 10.1002/cmdc.202100678
- By:
- Publication type:
- Article
9
Biguanide MC001, a Dual Inhibitor of OXPHOS and Glycolysis, Shows Enhanced Antitumor Activity Without Increasing Lactate Production.
- Published in:
- ChemMedChem, 2022, v. 17, n. 6, p. 1, doi. 10.1002/cmdc.202100674
- By:
- Publication type:
- Article
10
Selective Binding of Small Molecules to Vibrio cholerae DsbA Offers a Starting Point for the Design of Novel Antibacterials.
- Published in:
- ChemMedChem, 2022, v. 17, n. 6, p. 1, doi. 10.1002/cmdc.202100673
- By:
- Publication type:
- Article
11
Multifunctional Nanoaggregates Composed of Active CPUL1 and a Triphenylphosphine Derivative for Mitochondria‐Targeted Drug Delivery and Cell Imaging.
- Published in:
- ChemMedChem, 2022, v. 17, n. 6, p. 1, doi. 10.1002/cmdc.202100632
- By:
- Publication type:
- Article
12
Selective Galectin‐8N Ligands: The Design and Synthesis of Phthalazinone‐d‐Galactals.
- Published in:
- ChemMedChem, 2022, v. 17, n. 6, p. 1, doi. 10.1002/cmdc.202100575
- By:
- Publication type:
- Article
13
The Discovery and Structure‐Activity Evaluation of (+)‐Floyocidin B and Synthetic Analogs.
- Published in:
- ChemMedChem, 2022, v. 17, n. 6, p. 1, doi. 10.1002/cmdc.202100644
- By:
- Publication type:
- Article